It is shown that a small molecule inhibitor can successfully target the adipocyte/macrophage fatty acid-binding protein aP2, and that oral administration of the inhibitor can result in metabolic improvement and decreased atherosclerosis and insulin resistance in mice.
- Masato Furuhashi
- Gürol Tuncman
- Gökhan S. Hotamisligil